Ontipria (Tiotropium Bromide)

Tiotropium bromide, the active ingredient in Ontipria, is a long‑acting muscarinic antagonist presented as a inhalation powder for oral inhalation use. It is indicated for maintenance therapy in chronic obstructive pulmonary disease, particularly in patients with a history of exacerbations. GNH USA supplies Ontipria as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Ontipria as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ontipria is a long‑acting muscarinic antagonist that provides bronchodilation in chronic obstructive pulmonary disease (COPD). - Chronic obstructive pulmonary disease: Improves lung function and reduces the frequency of exacerbations. - Asthma (as add‑on therapy): Enhances symptom control when used with inhaled corticosteroids. - Chronic bronchitis: Decreases mucus production and eases airway obstruction.

Common Side Effects: - Dry dry dry     t    t  ...   t ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...

Serious or Rare Side Effects: -  ... …  …  ....  … … … … … … … … … … … … ... 

Ont   t  \n     t